'Very optimistic': Research offers hope for MND and Alzheimer's gene treatment
Original publication from The Lighthouse
Revolutionary gene therapies to treat motor neuron disease, Alzheimer’s and a severe form of childhood epilepsy may be just around the corner, with a new venture aiming to bring Macquarie University’s medical research to the world.
Fifteen years of work on degenerative brain diseases is soon to make the giant leap from the lab to human clinical trials in the form of a potential treatment for MND, the cruel disease that robs people of the ability to control their bodies, and eventually even to breathe.
And this is just the first of three exciting discoveries by Macquarie research teams being fast-tracked for development through a University spin-off company, Celosia Therapeutics.
Celosia Therapeutics was recently revealed as the second prize winner of a coveted Australia/New Zealand competition run by Cytiva, a leading global provider of technologies and services that advance and accelerate the development and manufacture of therapeutics.
The prize gives the University access to $100,000 worth of Cytiva services, which will be used to develop and refine the commercial manufacturing process, needed to turn successful lab research into real-world treatments ready for use by patients.
Read the full article here.